Walk in interview for M.Pharm, B.Pharm in Production at Medreich

Medreich facilities have received the seal of approval from leading global regulatory bodies such as -UK MHRA, Australia TGA, SA MCC, Health Canada, and French AFSSAP, GCC, PIC, regulatory bodies of various countries in the African continent and independent bodies like UNICEF and MSF.

Wanted Associate Trianee at Kenkyu Group

Kenkyu  Publishing Group is an independent open-access scientific publishing group . The main aim of Kenkyu Publishing Group is to provide a 'peer reviewed' platform to outstanding researchers and scientists to publish their research in an open-access Platform. Kenkyu  Publishing Group encourages the researches in all fields of Medical, Life science, Clinical, and Engineering.

Post : Associate Trianee - 02 posts

Work in Analytical Development at Mylan | M.Pharm, B.Pharm

Mylan is one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in more than 150 countries and territories. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. With a workforce of more than 16,000, Mylan has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service.

Post : Analytical Development (Solid Orals)

Vacancy for Senior Clinical Process Specialist at Quintiles

Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. We bring a fully integrated approach to build biopharma and life sciences solutions – from pipeline through portfolio to population health. A career with Quintiles connects you to great opportunity to achieve professional success and impact healthcare around the world.

Post : Senior Clinical Process Specialist

Medtronic looking for Senior Executive - Logistics

This is a question we’ve asked ourselves over and over. It’s how we at Medtronic have made hearts beat stronger and longer. It’s how we’ve pushed the limits of what technology can do in and for the body. It’s how we will continue to alleviate pain, restore health and extend life. Rising costs, an aging population, and the burden of chronic disease impact us all. And no single entity in the healthcare system can solve these challenges alone. That’s why we’re stepping forward. That’s why we’re prepared to put the full power of our technologies, services, resources — and our people — to work with new partners, in new ways, to usher in a new era in healthcare.

Post : Sr. Executive - Logistics

Burcon NutraScience Corporation is pleased to announce that it has been granted a U.S. patent, covering technology for the production of its Peazazz® pea protein:  U.S. patent no. 9,635,875, was granted on May 2, 2017.  This patent is the first to be granted for Burcon’s pea technology by the United States Patent and Trademark Office and confirms that the Company’s approach is unique, distinct and defensible.  Burcon anticipates further positive progress, with its patent filings, in due course.

AstraZeneca and MedImmune, its global biologics research and development arm,  announced that tralokinumab, an anti-interleukin-13 (IL-13) human monoclonal antibody, did not meet its primary endpoint of a significant reduction in the annual asthma exacerbation rate (AAER) in the overall population of severe, uncontrolled asthma patients, compared with placebo in STRATOS 1, the first of two pivotal Phase III trials.

Biocon's Bengaluru plant had inspected by USFDA between March 27 to April 7, 2017 and USFDA issued form no. 483 to Biocon, largest biotechnology company of India. USFDA observed total 8 issues which were shared with the company. Shares of Biocon fell down after this reports circulated in media.

Recruitment for M.Pharm, Pharm.D under IPC - Govt. of India | Remuneration Rs.80,000/- pm

The Indian Pharmacopoeia Commission (IPC) is an Autonomous Body under Ministry of Health & Family Welfare, Govt. of India primarily with the objectives of regularly updating the Indian Pharmacopoeia by publishing new edition and its addenda, National Formulary of India and other related tasks such as preparing, certification and distribution of reference substances & functions as National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI).

The Commission invites applications from the best knowledgeable professionals for appointment on Contract basis for the following positions:-

Post : Patient Safety- Pharmacovigilance Associate